Antiparkinson drugs--abuse among youth
Retterstol, N.
Tidsskrift for den Norske Laegeforening Tidsskrift for Praktisk Medicin Ny Raekke 93(31): 2332
1973
ISSN/ISBN: 0029-2001 PMID: 4771148 Document Number: 68253
Document emailed within 1 workday
Related Documents
Stock, B.; Spiteller, G. 1979: Metabolism of antiparkinson drugs. An example of competitive hydroxylation Arzneimittel-Forschung 29(4): 610-615Youdim, M.B. 1990: Inhibitors of dopamine inactivating systems as antiparkinson drugs Advances in Neurology 53: 483-488
David, J.; Kaul, C.L.; Grewal, R.S. 1979: Pharmacological & biochemical characterization of antiparkinson drugs in reserpinized mice Indian Journal of Experimental Biology 17(8): 760-764
Kim, S.; Crutchfield, C.; Williams, C.; Hepler, N. 1998: Toward a new paradigm in substance abuse and other problem behavior prevention for youth: youth development and empowerment approach Journal of Drug Education 28(1): 1-17
Scannapieco, M.; Painter, K.R.; Blau, G. 2018: A comparison of LGBTQ youth and heterosexual youth in the child welfare system: Mental health and substance abuse occurrence and outcomes Children and Youth Services Review 91: 39-46
Ben Hadj Ali, B.; Dogui, M.; Ben Ammou, S.; Lôo, H. 1995: Antiparkinson drugs in neuroleptic treatment: comparative study of progressive and abrupt withdrawal L'Encephale 21(3): 209-215
Carrington, A.; Dewar, S.; Kinchin, I.; Cadet-James, Y.; Tsey, K. 2019: A police-led community response to Child abuse and Youth Sexual Violence and Abuse in Indigenous communities in Far North Queensland: "Speak Up. be strong. be Heard." Child Abuse and Neglect 98: 104228
Martínez-Suárez, M.M.; Blázquez-Menes, B. 2000: Estimation of the prevalence of Parkinson's disease in Asturia, Spain. a pharmacoepidemiological study of the consumption of antiparkinson drugs Revista de Neurologia 31(11): 1001-1006
Maresova, V.; Chadt, J.; Novakova, E. 2008: Screening and semiquantitative analysis of drugs and drugs of abuse in human serum samples using gas chromatography-mass spectrometry Neuro Endocrinology Letters 29(5): 749-754
Estler, C.J. 1984: Drug interactions of central nervous system active drugs. 3: Drug interactions of anticonvulsants and antiparkinson agents Fortschritte der Medizin 102(6): 129-132
Fennelly, J.J. 1971: Drugs and their abuse no. V--misuse of cytotoxic drugs Journal of the Irish Medical Association 64(416): 383-384
Cohen, M.; Levin, S.H.; Gagin, R.; Friedman, G. 2007: Elder abuse: disparities between older people's disclosure of abuse, evident signs of abuse, and high risk of abuse Journal of the American Geriatrics Society 55(8): 1224-1230
Bates, N.D.; Army, C. 2015: Preventing child sexual abuse in youth-serving organizations Journal of Healthcare Protection Management: Publication of the International Association for Hospital Security 31(2): 71-79
Cameron, L.A. 1999: Understanding alcohol abuse in American Indian/Alaskan Native youth Pediatric nursing 25(3): 297-300
Lynch, T. 1971: Drugs and their abuse. IV. Sedative drugs Journal of the Irish Medical Association 64(415): 357-358
Midford, R 2008: Preventing Youth Substance Abuse: Science-Based Programs for Children and Adolescents Drug and Alcohol Review 27(5): 575-576
Iwasaki, Y. 2015: The role of youth engagement in positive youth development and social justice youth development for high-risk, marginalised youth International Journal of Adolescence and Youth 21(3): 267-278
Iwasaki, Y. 2015: The role of youth engagement in positive youth development and social justice youth development for high-risk, marginalised youth International Journal of Adolescence and Youth 21(3): 267-278
Iwasaki, Y. 2015: The role of youth engagement in positive youth development and social justice youth development for high-risk, marginalised youth International Journal of Adolescence and Youth 21(3): 267-278
Kern, R.; Lenz, H. 1972: Narcotics abuse of youth in Upper Austria. a field study of predominantly 15 to 16 year olds Wiener Medizinische Wochenschrift 122(25): 384-386